UroGen Pharma
URGN
$13.22
Share price
0.08%
Change (1 day)
11.09%
Change (1 year)
Categories
Earnings for UroGen Pharma (URGN)
Earnings in 2023 (TTM): -$98.33 M
According to UroGen Pharma's latest financial reports the company's current earnings (TTM) are -$98.33 M. In 2022 the company made an earning of -$0.11 B an increase over its 2021 earnings that were of -$0.11 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for UroGen Pharma from 2017 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$98.33 M | -8.98% |
| 2022 | -$0.11 B | -1.23% |
| 2021 | -$0.11 B | -12.58% |
| 2020 | -$0.13 B | 18.99% |
| 2019 | -$0.11 B | 39.21% |
| 2018 | -$75.54 M | 278.02% |
| 2017 | -$19.99 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 12.67% | 🇺🇸 USA |